596 results on '"Piano, Salvatore"'
Search Results
2. SAT-129 Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
3. Acute liver failure
4. Infections in cirrhosis
5. Infectious Complications of Portal Hypertension
6. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
7. Hepatorenal Syndrome in Cirrhosis
8. A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis
9. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
10. Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis
11. Bacterial Infections in Acute on Chronic Liver Failure
12. The SIMI Gender ‘5 Ws’ Rule for the integration of sex and gender-related variables in clinical studies towards internal medicine equitable research
13. Liver transplantation in the patient with physical frailty
14. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences
15. Preventing Further Decompensation: Consensus Statements of Panel 7
16. Prevention of Further Decompensation in Patients With Ascites
17. Cardiopulmonary Complications in Cirrhotic Patient with the Prospective of Liver Transplant
18. Modified quick-SOFA score: can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?
19. OS-035-YI Validating and expanding Baveno VII criteria of recompensation in patients with decompensated cirrhosis
20. THU-420 Evaluation of LiverRisk score as predictor of liver fibrosis and mortality in patients with HCV-related hepatitis treated with direct acting antivirals
21. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
22. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database
23. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
24. FRI-047-YI Predictors of ascites resolution in patients with cirrhosis receiving long-term albumin treatment. Results from a real-world study in Italy (Real-ANSWER)
25. THU-050 Urinary biomarkers of tubular and glomerular damage predict renal recovery in patients with hepatorenal syndrome-acute kidney injury
26. FRI-068 Predictors of clinical trajectories in patients surviving an acute decompensation of cirrhosis
27. WED-098-YI Low-density lipoprotein can predict hospital readmissions and outcomes following acute decompensation of cirrhosis
28. OS-038-YI Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury-results from the ICA-GLOBAL AKI study
29. THU-057-YI Distinguishing clinical profiles in acute-on-chronic liver failure: a comparative analysis of alcohol-related hepatitis versus infection precipitated acute-on-chronic liver failure
30. SAT-083-YI Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome-acute kidney injury
31. FRI-101-YI Rectus femoris cross sectional area predicts 90-day readmission in patients hospitalized for an acute decompensation of cirrhosis
32. Performance of non-invasive respiratory function indices in predicting clinical outcomes in patients hospitalized for COVID-19 pneumonia in medical and sub-intensive wards: a retrospective cohort study
33. Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
34. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
35. Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.
36. Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis.
37. CONTROVERSIES IN LIVER TRANSPLANTATION CORNER.
38. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis
39. Italian association for the study of the liver position statement on SARS-CoV2 vaccination
40. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?
41. An Integrated Review of the Hepatorenal Syndrome
42. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
43. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
44. miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals.
45. Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections--Results from the ICA "Global Study" (EABCIR-Global Study).
46. Acute Kidney Injury and Hepatorenal Syndrome
47. Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure
48. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
49. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation
50. Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.